The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Gene Review

Oas1b  -  2'-5' oligoadenylate synthetase 1B

Mus musculus

Synonyms: (2-5')oligo(A) synthase 1B, 2'-5'-oligoadenylate synthase-like protein 1, 2-5A synthase 1B, Flavivirus resistance, Flv, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Oas1b

  • Expression of the resistant allele of Oas1b in susceptible embryo fibroblasts resulted in partial inhibition of the replication of a flavivirus but not of an alpha togavirus [1].
  • A large body of evidence suggests a critical role for the 1b isoform of the mouse Oas gene (Oas1b) in resistance to West Nile virus (WNV) infection in vivo [2].
  • This study has revealed a clear segregation between flavivirus resistance conferred by the Flv locus and sensitivity to dopamine-controlled hypothermia conferred by a novel locus, Diht [3].
  • Expression of the two bovine papillomavirus type 1 (BPV-1) late genes, L1 and L2, coding for the two capsid proteins, is limited to terminally differentiated keratinocytes in bovine fibropapillomas [4].
  • In Western blot analysis of L1 proteins from different HPV types, antisera to the L1 peptide reacted only with HPV 16, thus identifying an HPV 16 type-specific linear epitope [5].

Psychiatry related information on Oas1b

  • Mutations in L1CAM, the gene encoding the transmembrane multifunctional neuronal adhesion molecule L1, are associated with neurodevelopmental disorders including X-linked hydrocephalus and mental retardation [6].

High impact information on Oas1b


Chemical compound and disease context of Oas1b

  • We have generated a diploid yeast strain that coexpresses the L1 and L2 capsid proteins of both HPV-6b and HPV-16, and we have purified fully assembled VLPs banding in a cesium chloride gradient at the expected density of 1.29-1.3 mg/ml [10].
  • The results suggested that reactivity of MAb HPV-16.I23 to L1 protein is lost when leucine 152 of the HPV-16 L1 protein is replaced by phenylalanine [11].
  • Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes [12].
  • In this work, we used a lactose-inducible system based on the Lactobacillus casei lactose operon promoter (plac) for expression of the HPV-16 L1 protein in L. casei [13].
  • HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase [14].

Biological context of Oas1b

  • The antiviral action of Oas1b was essentially restricted to the early stages in virus life cycle [2].
  • Mapping the Flv locus controlling resistance to flaviviruses on mouse chromosome 5 [15].
  • The phenotype of resistance/susceptibility is determined by a major locus, Wnv, mapping to chromosome 5 within the 0.4-cM-wide interval defined by markers D5Mit408 and D5Mit242 [16].
  • The observation that WN virus sensitivity of susceptible mice was completely correlated with the occurrence of a point mutation in 2'-5'-OAS L1 suggests that this isoform may play a critical role in WN pathogenesis [16].
  • L1 contains an open reading frame coding for a protein that shows 70% conservation at the amino acid level when compared to the protein predicted to be encoded by L3 [17].

Anatomical context of Oas1b

  • To investigate the molecular basis for the sensitivity of WNV to the Oas1b antiviral pathway, we established a stable mouse fibroblastic cell clone that up-regulates Oas1b protein expression under the control of the Tet-Off expression system [2].
  • We have generated Ba/F3 cell lines expressing a tamoxifen-inducible active FKHR-L1 mutant [FKHR-L1(A3):ER*] [18].
  • It is the founder of a neural group of related cell surface receptors that share with L1 a highly conserved cytoplasmic domain that associates with the cytoskeleton [19].
  • PCR analysis of human/rodent hybrid cell line DNA samples showed that the polymorphic L1 elements were located on several different chromosomes [20].
  • Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes [21].

Associations of Oas1b with chemical compounds

  • Linkage analysis of mouse strain-dependent coinheritance between flavivirus resistance and greater sensitivity to the hypothermic effect of dopamine was performed using two genetically unrelated flavivirus-susceptible and two highly congenic flavivirus-resistant mouse strains in parallel with C3H.PRI-Flv(r)-and C3H/HeJARC reference strains [3].
  • Actinomycin D chase experiments using BPV-1 L1 expression vectors indicated that the element does not destabilize cytoplasmic polyadenylated RNA [4].
  • Importantly, ingestion of transgenic L1 potato was associated with activation of an anti-VLP immune response in mice that was qualitatively similar to that induced by VLP parenteral administration, and this response was enhanced significantly by subsequent oral boosting with purified insect cell-derived VLPs [22].
  • L1 RNA, but not protein, was detected biochemically in C3 cells [23].
  • The method allows efficient one-step purification of L1 fusion protein from crude bacterial lysates on ELISA plates coated with glutathione casein [14].

Other interactions of Oas1b

  • The composite genetic map that has been constructed identifies three novel microsatellite loci, D5Mit68, D5Mit159, and D5Mit242, tightly linked to the Flv locus [24].
  • Southern analyses of ME12 and ME5/ME8 using L3, L1-specific and L2-specific probes indicate that these genes have a similar organization. cII was transiently and stably transfected into CV-1 cells [17].
  • This, together with the previous data produced by our group, locates Flv to a region on mouse Chr 5 carrying segments that are conserved on either human Chr 4, 12, or 7, but present knowledge does not allow precise identification of the syntenic element [24].
  • METHODS AND RESULTS: Transgenic mice from 2 different lineages with differing amounts of myocardial TNF-alpha expression [lineage 1 (L1) and lineage 2 (L2)] and littermate controls (LC) were studied [25].
  • We now show that the lack of immunogenicity of polynucleotide vaccines based on the L1 gene can be overcome with codon modified L1, which induces strong immune responses, including conformational virus neutralising antibody and delayed type hypersensitivity [26].

Analytical, diagnostic and therapeutic context of Oas1b

  • Comparing the cDNA sequences of 2'-5'-OAS L1, L2, and L3 isoforms, between susceptible and resistant strains, we identified a STOP codon in exon 4 of the gene encoding the L1 isoform in susceptible strains that can lead to a truncated form with amputation of one domain, whereas all resistant mice tested so far have a normal copy of this gene [16].
  • The new congenic mouse strains, which were created to carry the Flv(r)-like and Flv(mr) alleles on the standardized genetic background of susceptible mice, represent new animal models of flavivirus resistance conferred by these novel resistance alleles [27].
  • In protocol 1, cardiac output (CO) and stroke volume (SV) were measured by MRI and thermodilution (TD) in 15 mice (3 L1, 4 L2, 8 LC) [25].
  • In animal PV models, vaccination against L1 and/or L2 viral capsid proteins provides an efficient protection against infection, involving virus type-specific neutralizing antibodies [28].
  • Prophylactic vaccines based on the use of virus-like particles (VLPs) obtained by auto-assembly of L1 or L1 and L2 proteins produced by recombinant DNA technology are under phase I/II clinical trials for HPV6/11 associated with condylomas and for HPV16, the most frequent oncogenic genotype [28].


  1. Positional cloning of the murine flavivirus resistance gene. Perelygin, A.A., Scherbik, S.V., Zhulin, I.B., Stockman, B.M., Li, Y., Brinton, M.A. Proc. Natl. Acad. Sci. U.S.A. (2002) [Pubmed]
  2. The 2',5'-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells. Kajaste-Rudnitski, A., Mashimo, T., Frenkiel, M.P., Guénet, J.L., Lucas, M., Desprès, P. J. Biol. Chem. (2006) [Pubmed]
  3. A novel mouse Chr5 locus Diht controls dopamine-induced hypothermia. Stoddart, C.W., Martin-Iverson, M.T., Jablensky, A., Urosevi, N. Mamm. Genome (2004) [Pubmed]
  4. An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels. Furth, P.A., Baker, C.C. J. Virol. (1991) [Pubmed]
  5. Type-specific and cross-reactive epitopes in human papillomavirus type 16 capsid proteins. Beiss, B.K., Heimer, E., Felix, A., Burk, R.D., Ritter, D.B., Mallon, R.G., Kadish, A.S. Virology (1991) [Pubmed]
  6. Missense mutations in the extracellular domain of the human neural cell adhesion molecule L1 reduce neurite outgrowth of murine cerebellar neurons. Michelson, P., Hartwig, C., Schachner, M., Gal, A., Veske, A., Finckh, U. Hum. Mutat. (2002) [Pubmed]
  7. LINE drive. retrotransposition and genome instability. Kazazian, H.H., Goodier, J.L. Cell (2002) [Pubmed]
  8. The cell adhesion molecule l1 is required for chain migration of neural crest cells in the developing mouse gut. Anderson, R.B., Turner, K.N., Nikonenko, A.G., Hemperly, J., Schachner, M., Young, H.M. Gastroenterology (2006) [Pubmed]
  9. Tracking an embryonic L1 retrotransposition event. Prak, E.T., Dodson, A.W., Farkash, E.A., Kazazian, H.H. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  10. Yeast coexpression of human papillomavirus types 6 and 16 capsid proteins. Buonamassa, D.T., Greer, C.E., Capo, S., Yen, T.S., Galeotti, C.L., Bensi, G. Virology (2002) [Pubmed]
  11. Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses. Combita, A.L., Touzé, A., Bousarghin, L., Christensen, N.D., Coursaget, P. J. Virol. (2002) [Pubmed]
  12. Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes. Zhou, J., Crawford, L., McLean, L., Sun, X.Y., Stanley, M., Almond, N., Smith, G.L. J. Gen. Virol. (1990) [Pubmed]
  13. Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells. Aires, K.A., Cianciarullo, A.M., Carneiro, S.M., Villa, L.L., Boccardo, E., Pérez-Martinez, G., Perez-Arellano, I., Oliveira, M.L., Ho, P.L. Appl. Environ. Microbiol. (2006) [Pubmed]
  14. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. Sehr, P., Müller, M., Höpfl, R., Widschwendter, A., Pawlita, M. J. Virol. Methods (2002) [Pubmed]
  15. Mapping the Flv locus controlling resistance to flaviviruses on mouse chromosome 5. Sangster, M.Y., Urosevic, N., Mansfield, J.P., Mackenzie, J.S., Shellam, G.R. J. Virol. (1994) [Pubmed]
  16. A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Mashimo, T., Lucas, M., Simon-Chazottes, D., Frenkiel, M.P., Montagutelli, X., Ceccaldi, P.E., Deubel, V., Guenet, J.L., Despres, P. Proc. Natl. Acad. Sci. U.S.A. (2002) [Pubmed]
  17. The murine 2-5A synthetase locus: three distinct transcripts from two linked genes. Rutherford, M.N., Kumar, A., Nissim, A., Chebath, J., Williams, B.R. Nucleic Acids Res. (1991) [Pubmed]
  18. Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Dijkers, P.F., Medema, R.H., Pals, C., Banerji, L., Thomas, N.S., Lam, E.W., Burgering, B.M., Raaijmakers, J.A., Lammers, J.W., Koenderman, L., Coffer, P.J. Mol. Cell. Biol. (2000) [Pubmed]
  19. Neural cell recognition molecule L1: from cell biology to human hereditary brain malformations. Brümmendorf, T., Kenwrick, S., Rathjen, F.G. Curr. Opin. Neurobiol. (1998) [Pubmed]
  20. Reading between the LINEs: human genomic variation induced by LINE-1 retrotransposition. Sheen, F.M., Sherry, S.T., Risch, G.M., Robichaux, M., Nasidze, I., Stoneking, M., Batzer, M.A., Swergold, G.D. Genome Res. (2000) [Pubmed]
  21. Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes. Dupuy, C., Buzoni-Gatel, D., Touzé, A., Bout, D., Coursaget, P. J. Virol. (1999) [Pubmed]
  22. Oral immunogenicity of human papillomavirus-like particles expressed in potato. Warzecha, H., Mason, H.S., Lane, C., Tryggvesson, A., Rybicki, E., Williamson, A.L., Clements, J.D., Rose, R.C. J. Virol. (2003) [Pubmed]
  23. L1-specific protection from tumor challenge elicited by HPV16 virus-like particles. De Bruijn, M.L., Greenstone, H.L., Vermeulen, H., Melief, C.J., Lowy, D.R., Schiller, J.T., Kast, W.M. Virology (1998) [Pubmed]
  24. Low resolution mapping around the flavivirus resistance locus (Flv) on mouse chromosome 5. Urosevic, N., Mansfield, J.P., Mackenzie, J.S., Shellam, G.R. Mamm. Genome (1995) [Pubmed]
  25. Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Franco, F., Thomas, G.D., Giroir, B., Bryant, D., Bullock, M.C., Chwialkowski, M.C., Victor, R.G., Peshock, R.M. Circulation (1999) [Pubmed]
  26. Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. Liu, W.J., Zhao, K.N., Gao, F.G., Leggatt, G.R., Fernando, G.J., Frazer, I.H. Vaccine (2001) [Pubmed]
  27. Development and characterization of new flavivirus-resistant mouse strains bearing Flv(r)-like and Flv(mr) alleles from wild or wild-derived mice. Urosevic, N., Silvia, O.J., Sangster, M.Y., Mansfield, J.P., Hodgetts, S.I., Shellam, G.R. J. Gen. Virol. (1999) [Pubmed]
  28. Human papillomavirus vaccines. Breitburd, F., Coursaget, P. Semin. Cancer Biol. (1999) [Pubmed]
WikiGenes - Universities